Design: Dual-centre consecutive case series.
Materials: Between 1999 and 2011, 102 patients underwent TEVAR for non-traumatic acute complicated type B dissection in Zurich, Switzerland, and Uppsala, Sweden. In addition, 22 patients treated for an acute dissection-related complication occurring >14 days after onset of symptoms were included. Median age was 68 years, 35% were women.
Methods: click here Demographic,
procedural and outcome data were collected prospectively. The patients were followed up on 1 January 2012.
Results: In the 22 sub-acute patients (18%), there were no early deaths or neurological complications. The predominant complication in these patients was rapid aortic enlargement, whereas rupture was more prevalent in patients treated within 14 days. In total, there were nine (7%) early deaths, three (2%) post-intervention paraplegias and six cases of stroke (5%).
Conclusions: TEVAR was performed with low early mortality and few neurological
complications. A significant proportion of patients presented with acute complications >14 days after onset of symptoms, indicative of a sub-acute phase in the transition between acute and chronic dissection, questioning the relevance of the current definition. (C) 2013 European Society for IACS-10759 supplier Vascular Surgery. Published by Elsevier Ltd. All rights reserved.”
“Objective: To provide evidence regarding existing partnerships between academic pharmacy and primary care
that focus on training practitioners in patient-centered health care (PCHC).
Data sources: The report of the 2009-10 American Association of Colleges of Pharmacy Professional Affairs Committee identified 25 current U. S.-based examples of PCHC that incorporate the training and preparation of both student pharmacists and pharmacy residents.
Summary: The most frequently reported health care delivery model was an ambulatory care clinic followed by a Department of Veterans Affairs or military hospital clinic. Pharmacists worked alongside a variety of other health care providers in these learn more settings. Collaboration occurred most commonly with family and internal medicine physicians but also with specialists such as psychiatrists, obstetricians/gynecologists, hematologists/oncologists, and other health care providers (e.g., nurses, physician assistants, dieticians, social workers).
Conclusion: In light of the increasing demand for primary care services, pharmacists’ documented ability to address these needs and the resulting benefits to patients, providers, and systems in these models, developing strategies for promoting pharmacist integration into PCHC is essential.